Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2007
11/22/2007US20070270453 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
11/22/2007US20070270441 Combination
11/22/2007US20070270422 Aromatic Compounds
11/22/2007US20070270421 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
11/22/2007US20070270420 Heteroaryl compounds useful as inhibitors of gsk-3
11/22/2007US20070270419 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors
11/22/2007US20070270418 Inhibitors of P38 and Methods of Using the Same
11/22/2007US20070270361 Sars Nucleic Acids, Proteins, Vaccines, and Uses Thereof
11/22/2007US20070270360 Rna Interference Mediated Inhibition of Severe Acute Respiratory Syndrome (Sars) Gene Expression Using Short Interfering Nucleic Acid
11/22/2007US20070270340 Biodrugs comprising polypeptides and carriers comprising bioadhesives such as fibrin, for treatment of vision defects; chimeric C3-like Rho antagonists and their use for promoting repair and neuron survival in injured mammalian central and peripheral nervous system and for treating cancer
11/22/2007US20070270330 Preventing airway mucus production by administration of egf-r antagonists
11/22/2007US20070269374 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction
11/22/2007DE102006023770A1 Treibgasfreie Aerosolformulierung für die Inhalation Propellant-free aerosol formulation for inhalation
11/22/2007DE102006023560A1 Use of biocomplex-reaction pattern in vertebrate cells preparation e.g. primary therapy for idiopathic pulmonary fibrosis and as adjuvant therapy for cytostatics, for steroidal and non-steroidal anti-inflammatory drugs
11/22/2007CA2652345A1 Methods and compositions for treatment of sleep apnea related applications
11/22/2007CA2651765A1 A medicament containing a thiazole derivative as an active ingredient
11/21/2007EP1857445A2 Substituted 2 amino imidazoles, method for their manufacture and their use as a drug or diagnostic and drug containing them
11/21/2007EP1857443A2 Therapeutic morpholino-substituted compounds
11/21/2007EP1857146A1 Treatment of respiratory disorders
11/21/2007EP1857115A2 Using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
11/21/2007EP1857113A2 Method and materials for treating asthma
11/21/2007EP1857110A2 Hormone replacement therapy
11/21/2007EP1857106A1 Combinations of erdosteine and beta-2 agonists for treating COPD
11/21/2007EP1857101A2 Medicaments
11/21/2007EP1856094A1 Microcrystalline (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)acetic acid
11/21/2007EP1856093A1 Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
11/21/2007EP1856092A1 6-heteroaryl-1,2,3,4,4a,10b-hexahydro-phenanthridines as pde-4 inhibitors for the treatment of inflammatory disorders
11/21/2007EP1856063A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
11/21/2007EP1856050A1 Crystalline forms of a biphenyl compound
11/21/2007EP1856045A1 1-acetic acid-indole derivatives with pgd2 antagonist activity
11/21/2007EP1855689A1 Pharmaceutical compositions comprising anticholinergics and etiprednol
11/21/2007EP1855673A2 Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders
11/21/2007EP1663982B1 Aminoquinoline derivatives and their use as adenosine a3 ligands
11/21/2007EP1534707B1 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/21/2007EP1505975B1 Compositions and method for treating infection in cattle and swine
11/21/2007EP1431284B1 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
11/21/2007EP1301500B1 Nitrosated and nitrosylated taxanes, compositions and methods of use
11/21/2007EP1269196B1 Method of screening for inhibitors of osteopontin
11/21/2007EP1056728B1 Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines
11/21/2007EP0842196B1 Cell adhesion inhibitors
11/21/2007CN101076591A Novel human virus causing respiratory tract infection and uses thereof
11/21/2007CN101076521A Process for producing muscarine receptor antagonist and intermediate therefor
11/21/2007CN101076368A Method and device for treating osteoarthritis and cartilage diseases, defects and injuries of the knee joint
11/21/2007CN101076352A Il-15 antigen array and its application
11/21/2007CN101074442A Recombinant expression and use for pertussis vaccine protective antigen
11/21/2007CN101074210A Pharmaceutically active isoindoline derivatives
11/21/2007CN101073656A Pear antitussive syrup with antasthmatic and lung-moistening functions
11/21/2007CN101073630A Externally-applied cream for treating various diseases
11/21/2007CN101073616A Compound nebula for treating rhinitis
11/21/2007CN101073595A Glycyrrhiza total flavonoid and total saponin extract and its production
11/21/2007CN101073594A Method for producing platycodon Root lozenge in treatment of chronic pharyngitis
11/21/2007CN101073582A Chinese medicine for treating otitis media and rhinitis
11/21/2007CN101073569A Medicine for preventing respiratory viruses and its use
11/21/2007CN101073563A Chiral composition containing dextrothyroxine buprofenli and levomethadyl cysteliqin and its double slow-releasing tablet
11/21/2007CN101073428A Hongjingtian Chinese-medicinal beverage
11/21/2007CN101073362A Throat-protecting tea
11/21/2007CN101073360A Throat-protecting tea
11/21/2007CN101073352A Anti-inflammatory tea with throat-clearing function
11/21/2007CN101073348A Health-care tea soup with lung-moistening and cough-stopping functions
11/21/2007CN101073347A Health-care tea soup with heat-clearing and antitussive functions
11/21/2007CN100349893C Substituted 2,4-dihydro-pyrrolo[3,4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/21/2007CN100349862C 大麻素受体配体 Cannabinoid receptor ligands
11/21/2007CN100349590C Medicinal use of glutinous rehmannia stem and leaf and its extract for preventing asthma and anti-allergy
11/21/2007CN100349589C Medical application of rehmannia root extractive in resisting asthma and allergy
11/21/2007CN100349584C Dropping pill for treating throat disease and preparing method thereof
11/21/2007CN100349564C Low alcohol type concentrated soloution for nourishing yin to clear away the lung-heat, preparation method and application
11/20/2007US7297818 Adamantane derivatives
11/20/2007US7297703 Macrolides
11/20/2007US7297696 Antiarthritic agents; antihistamines; atherosclerosis; multiple sclerosis; Crohn's disease; nephritis; pancreastitis; skin disorders; restenosis; prevent leukocyte migration
11/20/2007US7297692 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
11/20/2007US7297526 Human DNase
11/20/2007US7297523 Human elongase genes and uses thereof
11/20/2007US7297346 For therapy of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain attention deficit hyperactivity disorder and fatigue
11/20/2007CA2441549C Ipratropium formulation for pulmonary inhalation
11/20/2007CA2300289C A pharmaceutical composition active in reducing production of mcp-1 protein
11/20/2007CA2140382C Vitamin d compounds and method of preparing these compounds
11/15/2007WO2007129963A1 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
11/15/2007WO2007129962A1 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
11/15/2007WO2007129743A1 Anti-inflammatory composition
11/15/2007WO2007129646A1 Macrolide derivative
11/15/2007WO2007129473A1 Bicyclic aryl derivative
11/15/2007WO2007129060A1 Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors
11/15/2007WO2007129048A1 Thiazole derivatives as inhibitors of p13 kinase
11/15/2007WO2007129005A1 Aminoacid derivatives of thiazoles as inhibitors of pi3 kinase
11/15/2007WO2007109355A3 6,7,8, 9 -tetrahydro- 5h- pyrimido [4, 5-d] azepin-4-yl] -amine derivatives as modulators of trpvl for the treatment of pain
11/15/2007WO2007080546A3 Compositions and methods useful for treatment of respiratory illness
11/15/2007US20070265316 2-(2-Chloro-benzoylamino)-4,5,6,7-tetrahydro-benzo thiophene-3-carboxylic acid amide; increasing activity of mutant-cystic fibrosis transmembrane conductance regulator protein in a cell; increasing halide ion permeability of a cell producing a Delta F508-CFTR protein
11/15/2007US20070265310 Biphenyl compounds useful as muscarinic receptor antagonists
11/15/2007US20070265308 5-[5-(2-chloro-4-fluorophenyl)-2-piperidin-4-yl-1,3-thiazol-4-yl]-1-(2,6-dichlorophenyl)pyridin-2(1H)-one; p38 MAP kinase inhibitory activity; inflammatory, respiratory , circulatory and central nervous diseases; rheumatoid arthritis
11/15/2007US20070265305 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; biphenyl carbamate derivative
11/15/2007US20070265303 5-[(1R)-2-({2-[4-(4-{3-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-hydroxyphenyl}butoxy)phenyl]ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1H)-one; chronic obstructive pulmonary disease (COPD), allergies
11/15/2007US20070265299 Compounds for the treatment of inflammatory disorders
11/15/2007US20070265294 Formulations and methods for vascular permeability-related diseases or conditions
11/15/2007US20070265280 Methods of using sodium channel blockers
11/15/2007US20070265273 Pyrimidin-2-Amine Derivatives and Their Use as A2b Adenosine Receptor Antagonists
11/15/2007US20070265236 Asthma Treatment Methods
11/15/2007US20070265228 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis
11/15/2007US20070265201 Inhibitors of inflammatory cytokine transcription derived from hcmv protein ie2
11/15/2007US20070265188 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
11/15/2007US20070264267 Nucleotide sequences coding zinc transport protein for use in diagnosis, prevention and treatment of cell proliferative disorders
1 ... 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 ... 878